IL77083A - Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof - Google Patents

Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof

Info

Publication number
IL77083A
IL77083A IL77083A IL7708385A IL77083A IL 77083 A IL77083 A IL 77083A IL 77083 A IL77083 A IL 77083A IL 7708385 A IL7708385 A IL 7708385A IL 77083 A IL77083 A IL 77083A
Authority
IL
Israel
Prior art keywords
histidyl
acyl
salts
manufacture
treatment
Prior art date
Application number
IL77083A
Other languages
English (en)
Other versions
IL77083A0 (en
Original Assignee
Gruenenthal Chemie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE19843447260 external-priority patent/DE3447260A1/de
Application filed by Gruenenthal Chemie filed Critical Gruenenthal Chemie
Publication of IL77083A0 publication Critical patent/IL77083A0/xx
Publication of IL77083A publication Critical patent/IL77083A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
IL77083A 1984-12-18 1985-11-18 Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof IL77083A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3446127 1984-12-18
DE19843447260 DE3447260A1 (de) 1984-12-22 1984-12-22 Verwendung von dipeptidderivaten zur behandlung von an amyotropher lateralsklerose erkrankten

Publications (2)

Publication Number Publication Date
IL77083A0 IL77083A0 (en) 1986-04-29
IL77083A true IL77083A (en) 1991-06-10

Family

ID=25827483

Family Applications (1)

Application Number Title Priority Date Filing Date
IL77083A IL77083A (en) 1984-12-18 1985-11-18 Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof

Country Status (8)

Country Link
US (1) US4788179A (da)
EP (1) EP0185210B1 (da)
JP (1) JPH0637395B2 (da)
DE (1) DE3583220D1 (da)
DK (1) DK585985A (da)
IE (1) IE58849B1 (da)
IL (1) IL77083A (da)
SG (1) SG81391G (da)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63316724A (ja) * 1987-06-19 1988-12-26 Nippon Shinyaku Co Ltd 抗けいれん剤
US5151497A (en) * 1989-02-21 1992-09-29 Japan Tobacco Inc. Histidyl peptide derivatives
CA2235350C (en) * 1994-11-08 2009-01-06 Avicena Group, Inc. Use of creatine or creatine analogs for the treatment of diseases of the nervous system
DE69625230T2 (de) * 1995-10-24 2003-09-04 Merck & Co., Inc. Thrombininhibitoren
US20050233973A1 (en) * 1997-10-09 2005-10-20 Albert Sattin Tri-peptides for antidepressant applications
US20020151502A1 (en) * 1997-10-09 2002-10-17 Albert Sattin Tri-peptides for neurological and neurobehavior applications
US6475989B1 (en) 1997-10-09 2002-11-05 Albert Sattin Use of pyroglutamyl-glutamyl-prolyl amide (EEP) for neurological and neurobehavioral disorders
US20060128671A1 (en) * 1998-04-02 2006-06-15 The General Hospital Corporation Compositions containing a combination of a creatine compound and a second agent
EP1065931A4 (en) * 1998-04-02 2006-10-11 Avicena Group Inc COMPOSITIONS CONTAINING CREATINE COMBINED WITH A SECOND AGENT
WO2002050056A1 (en) 2000-12-18 2002-06-27 Merck & Co., Inc. Benzylamine derivatives and their use as thrombin inhibitors
US6528503B2 (en) 2000-12-18 2003-03-04 Merck & Co., Inc. Thrombin inhibitors
US8015737B2 (en) * 2001-02-08 2011-09-13 Venegas Jr Frank Barrier cover
US7144899B2 (en) 2001-02-09 2006-12-05 Merck & Co., Inc. Thrombin inhibitors
US7084134B2 (en) 2002-05-02 2006-08-01 Merk & Co., Inc. Thrombin inhibitors
US20040126366A1 (en) * 2002-06-04 2004-07-01 Rima Kaddurah-Daouk Methods of treating cognitive dysfunction by modulating brain energy metabolism
US7462595B2 (en) * 2004-09-17 2008-12-09 Prange Jr Arthur Jergen Methods for treating cancer-related fatigue
WO2007133673A2 (en) * 2006-05-11 2007-11-22 Avicena Group, Inc. Methods of treating a neurological disorder with creatine monohydrate
US9233099B2 (en) 2012-01-11 2016-01-12 University Of Cincinnati Methods of treating cognitive dysfunction by modulating brain energy metabolism

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE408300B (sv) * 1974-10-16 1979-06-05 Gruenenthal Chemie Sett att framstella nya dipeptidderivat
DE2615455C2 (de) * 1976-04-09 1985-06-20 Grünenthal GmbH, 5190 Stolberg N-Acyl-L-histidyl-L-prolin (N-substituierte)-amide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Zubereitungen
HU180926B (en) * 1979-06-28 1983-05-30 Richter Gedeon Vegyeszet Process for preparing trh analogues,tripeptide amides infectives on the central nerve sysrhem
US4608365A (en) * 1984-03-30 1986-08-26 University Of Southern California Treatment of neurologic functions

Also Published As

Publication number Publication date
JPH0637395B2 (ja) 1994-05-18
EP0185210B1 (de) 1991-06-12
IE852697L (en) 1986-06-18
US4788179A (en) 1988-11-29
IE58849B1 (en) 1993-11-17
DK585985D0 (da) 1985-12-17
SG81391G (en) 1991-11-15
EP0185210A3 (en) 1988-09-14
DE3583220D1 (de) 1991-07-18
EP0185210A2 (de) 1986-06-25
DK585985A (da) 1986-06-19
IL77083A0 (en) 1986-04-29
JPS61145121A (ja) 1986-07-02

Similar Documents

Publication Publication Date Title
PT81746A (en) Process for the preparation of peptide-aldehydes and of pharmaceutical compositions containing them
IT8449164A0 (it) Ti sucralfat e procedimento per la composizioni farmaceutiche contenenloro stabilizzazione
IL86089A (en) Pharmaceutical compositions containing certain androstane-17-ones for the prophylaxis and therapy of retroviral infections
IL76591A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment or prevention of malignant or viral diseases
PT81007A (en) Process for the preparation of analgesic 1,2-benzisothiazol-3-ylpiperazine derivatives and of pharmaceutical compositions containing the same
IL77083A (en) Pharmaceutical compositions containing certain n-acyl-histidyl-prolinamide derivatives or salts thereof for the treatment of amyothropic lateral sclerosis and manufacture thereof
PT82030A (en) Process for the preparation of 4-substituted androstendione derivatives and of pharmaceutical compositions containing the same
PT81015B (en) Process for the preparation of piridazo-diazocine derivatives and pharmaceutical compositions therewith
IL76561A (en) Pharmaceutical compositions containing ifn-ypsilon for the treatment of rheumatic diseases
GB2167746B (en) A process for the preparation of isosilybin-free silibinin and pharmaceutical compositions containing it
PT80246A (en) Process for the preparation of novel cephalosporin derivatives and of pharmaceutical compositions containing the same
IL88159A0 (en) Salts of pentamidine and pharmaceutical compositions containing the same
PT82984A (en) Process for the preparation of poly-4-aminopyrrole-2-carboxamido derivatives and of pharmaceutical compositions containing the same
PT83495A (en) Process for the preparation of n-substituted diphenylpiperidines and of pharmaceutical compositions containing the same
PH23447A (en) B-actam compounds,pharmaceutical compositions containing the same and method of use thereof
PT80794A (en) Process for the preparation of novel isoindolinyl-alkyl-piperazines and of pharmaceutical compositions containing the same
DE3261760D1 (en) Pharmaceutical compositions for the treatment of skin
PT79858A (en) Process for the preparation of azolyl-aryl-alcanol and pharmaceutical compositions therewith
GB2162748B (en) Medicinal composition for the treatment or prevention of acne by oral administration
GB2105992B (en) Pharmaceutical composition for treatment of cardio-vascular diseases
GB8522336D0 (en) Composition for treatment of allergies
DE3277171D1 (en) Pharmaceutical composition and the use of sn- or cr-protoporphyrin for the manufacture thereof
PT81083A (en) Process for the preparation of substituted 7-oxomitosanes and of pharmaceutical compositions containing the same
DE3272384D1 (en) Medicinal composition for the treatment of certain neuroviroses
GB2161382B (en) Pharmaceutical and cosmetic compositions containing 1 8-dihydroxy-10-phenyl-9-anthrone and process for the preparation of this compound

Legal Events

Date Code Title Description
RH Patent void